Sun Pharmaceutical Industries Limited

Price Chart

Risk-Adjusted Performance

Sun Pharmaceutical Industries Limited (SUNPHARMA) Price Performance

Sun Pharmaceutical Industries Limited (SUNPHARMA) trades on NSE in INR. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at INR1675.50, down 1.04% from the previous close.

Over the past year, SUNPHARMA has traded between a low of INR1553.21 and a high of INR1825.90. The stock has gained 5.5% over this period. It is currently 8.2% below its 52-week high.

Sun Pharmaceutical Industries Limited has a market capitalization of $4.06T, with a price-to-earnings ratio of 37.24 and a dividend yield of 0.97%.

About Sun Pharmaceutical Industries Limited

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations, and active pharmaceutical ingredients (APIs) in India, the United States, and internationally. The company offers formulations in various therapeutic areas, including neuropsychiatry, cardiology, diabetes, gastroenterology, pain/analgesics, gynecology, ophthalmology, urology, dermatology, respiratory, anti-infectives, oncology, psychiatry, neurology, orthopaedic, nephrology, urology, dermatology, respiratory, dental, and nutritionals. It also provides generic medications, such as tablets, capsules, injectables, inhalers, ointments, creams, and liquids; speciality medications; antiretrovirals medications; and over-the-counter products, such as vitamins, analgesics, digestives, and lifestyle. In addition, the company offers APIs for anti-cancers, peptides, steroids, sex hormones, immunosuppressant drugs, and controlled substances. It exports its products to approximately 90 countries across Asia, North America, Europe, Africa, South America, and Australia. Sun Pharmaceutical Industries Limited was founded in 1983 and is headquartered in Mumbai, India.